Overall, the c-Myc transgenic mouse model is responsive to the genotoxic carcinogen NDEA and may possibly differentiate between safe and hazardous chemicals as evidenced by the development of hepatocellular carcinoma already at the age of 5.5 months. The gene discussed is MYC; the disease is hepatocellular carcinoma.